You are here

Roche says 2017 profit growth unlikely to outstrip sales

Mr Schwan is playing down the threat posed by US President Donald Trump's call for drugmakers to cut prices and invest more in America, arguing that innovative companies will still be rewarded.


ROCHE on Wednesday forecast that profit growth would not outstrip sales in 2017 as the world's top cancer drugmaker increases spending on new products that it hopes will offset declines in ageing biotech medicines now going off patent.

The Swiss drugmaker dismissed...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to